Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

Affiliations

• ¹ Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK; Chinese Academy of Medical Science, Oxford Institute, University of Oxford, Oxford OX3 9DU, UK.
• ² Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
• ³ Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK.
• ⁴ Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, University of Oxford, Oxford OX3 9DU, UK.
• ⁵ Chinese Academy of Medical Science, Oxford Institute, University of Oxford, Oxford OX3 9DU, UK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
• ⁶ NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, University of Oxford, Oxford OX3 9DU, UK; Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK.
• ⁷ Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK; Chinese Academy of Medical Science, Oxford Institute, University of Oxford, Oxford OX3 9DU, UK; Division of Structural Biology, University of Oxford, Oxford OX3 9DU, UK; Diamond Light Source, Harwell Science and Innovation Campus, Didcot, UK; Division of Structural Biology, Wellcome Centre for Human Genetics, Oxford, UK; Instruct-ERIC, Oxford House, Oxford, UK.
• ⁸ Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK; Chinese Academy of Medical Science, Oxford Institute, University of Oxford, Oxford OX3 9DU, UK; Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Dean Office for Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Salaya, Thailand.
• ⁹ Division of Epidemiology and Public Health, University of Nottingham School of Medicine, Nottingham, UK.
• ¹⁰ Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, University of Oxford, Oxford OX3 9DU, UK. Electronic address: matthew.snape@paediatrics.ox.ac.uk.